Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - calcitonin salmon, quantity: 50 iu/ml - injection, solution - excipient ingredients: water for injections; glacial acetic acid; sodium chloride; sodium acetate - - active paget's diseasein patients who do not respond to alternative treatments or for whom such treatments are not suitable,- hypercalcaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - calcitonin salmon, quantity: 100 iu/ml - injection, solution - excipient ingredients: sodium acetate; sodium chloride; glacial acetic acid; water for injections - - active paget's diseasein patients who do not respond to alternative treatments or for whom such treatments are not suitable,- hypercalcaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

universal specialities ltd trading as usl medical - ascorbic acid 0.187%; ethanol 0.9%; glacial acetic acid 0.55%; ipecacuanha liquid extract 0.3% - syrup - active: ascorbic acid 0.187% ethanol 0.9% glacial acetic acid 0.55% ipecacuanha liquid extract 0.3% excipient: glycerol

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - exenatide 250 µg/ml;   - solution for injection - 10µg/40µl - active: exenatide 250 µg/ml   excipient: glacial acetic acid mannitol metacresol sodium acetate trihydrate water for injection - adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of metformin and a sulfonylurea but are not achieving adequate glycaemic control. to improve glycaemic control in patients with type 2 diabetes mellitus in combination with a basal insulin with or without metformin and/or a thiozolidinedione.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - exenatide 250 µg/ml;   - solution for injection - 5µg/20µl - active: exenatide 250 µg/ml   excipient: glacial acetic acid mannitol metacresol sodium acetate trihydrate water for injection - adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of metformin and a sulfonylurea but are not achieving adequate glycaemic control. to improve glycaemic control in patients with type 2 diabetes mellitus in combination with a basal insulin with or without metformin and/or a thiozolidinedione.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciprofloxacin hydrochloride 2.33mg equivalent to ciprofloxacin 0.2% w/v; hydrocortisone 10mg equivalent to 1% w/v hydrocortisone;  ;  ; ciprofloxacin hydrochloride 2.33mg equivalent to ciprofloxacin 0.2% w/v; hydrocortisone 10mg equivalent to 1% w/v hydrocortisone - ear drops - active: ciprofloxacin hydrochloride 2.33mg equivalent to ciprofloxacin 0.2% w/v hydrocortisone 10mg equivalent to 1% w/v hydrocortisone     excipient: benzyl alcohol glacial acetic acid lecithin polysorbate 20 polyvinyl alcohol purified water sodium acetate trihydrate sodium chloride active: ciprofloxacin hydrochloride 2.33mg equivalent to ciprofloxacin 0.2% w/v hydrocortisone 10mg equivalent to 1% w/v hydrocortisone excipient: benzyl alcohol glacial acetic acid lecithin polysorbate 20 polyvinyl alcohol purified water sodium acetate trihydrate sodium chloride - the treatment of acute bacterial external otitis caused by organisms susceptible to the action of ciprofloxacin, including pseudomonas aeruginosa, staphylococcus aureus, acinetobacter anitratus (baumannii), stenotrophomonas maltophilia, enterobacteriaceae, enterococcus faecalis and proteus mirabilis.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius medical care australia pty ltd (nz) - calcium chloride dihydrate 4.6 g/l; glacial acetic acid 6.3 g/l; magnesium chloride hexahydrate 1.4 g/l; potassium chloride 2.6 g/l; sodium chloride 210.7 g/l - dialysis solution - active: calcium chloride dihydrate 4.6 g/l glacial acetic acid 6.3 g/l magnesium chloride hexahydrate 1.4 g/l potassium chloride 2.6 g/l sodium chloride 210.7 g/l excipient: purified water sodium hypochlorite

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius medical care australia pty ltd (nz) - calcium chloride dihydrate 8.9 g/l; glacial acetic acid 11.2 g/l; magnesium chloride hexahydrate 4.8 g/l; potassium chloride 7 g/l; sodium chloride 283.6 g/l - dialysis solution - active: calcium chloride dihydrate 8.9 g/l glacial acetic acid 11.2 g/l magnesium chloride hexahydrate 4.8 g/l potassium chloride 7 g/l sodium chloride 283.6 g/l excipient: purified water sodium hypochlorite

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius medical care australia pty ltd (nz) - calcium chloride dihydrate 8.9 g/l; glacial acetic acid 11.2 g/l (trace elements from tank and line process); magnesium chloride hexahydrate 4.8 g/l; potassium chloride 3.5 g/l; sodium chloride 283.6 g/l - dialysis solution - active: calcium chloride dihydrate 8.9 g/l glacial acetic acid 11.2 g/l (trace elements from tank and line process) magnesium chloride hexahydrate 4.8 g/l potassium chloride 3.5 g/l sodium chloride 283.6 g/l excipient: purified water sodium hypochlorite

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius medical care australia pty ltd (nz) - calcium chloride dihydrate 7.7 g/l; glacial acetic acid 4.2 g/l; magnesium chloride hexahydrate 3.6 g/l; potassium chloride 2.6 g/l; sodium chloride 214.8 g/l - dialysis solution - active: calcium chloride dihydrate 7.7 g/l glacial acetic acid 4.2 g/l magnesium chloride hexahydrate 3.6 g/l potassium chloride 2.6 g/l sodium chloride 214.8 g/l excipient: purified water sodium hypochlorite